Industry Q&A: Solving Supply Chain Pressures with Reverse Logistics We’re living through the Great Supply Chain Reckoning as orthopedics firms grapple with material availability, shortages, and shipping delays worldwide. For OEMs of all sizes, disruption continues to dominate the outlook through the end of 2021 and well into next year. As we look…
Industry Q&A: Five Questions on 2022 Trends and System Integration Services In the perpetual quest for increased efficiency, visibility, and business performance, medtech OEMs are turning to better tools to help them master today’s market. This is especially important given the market’s rapid changes. As we look to 2022, Millstone is sharing industry…
Building Resiliency for the Next Big Supply Chain Interruption Supply chain resilience continues to be the headline story of 2021, in the orthopedic medical device industry as well as across industries. As we look to the post-COVID period, what has the orthopedic industry learned about managing complexity, forecasting, sourcing, risk, and supply chain…
Industry Q&A: Common Pitfalls of Orthopedic Robotic Assisted Surgery Product Launches Robotic assisted surgery products were already on the ascent in the orthopedic space well before COVID-19, but the pandemic may just prove to be a booster for their continued adoption and growth. Stryker’s acquisition of Mako Surgical in 2013 paved…
Four Key Strategies to Advance Supply Chain Visibility and Resilience What’s keeping large global orthopedic manufacturers and suppliers up at night? Supply chain visibility and resilience. This isn’t a surprise, as the supply chain reckoning and global shocks of the last year have revealed true vulnerability in supply bases worldwide. Nearly 18 months…
Three Reasons Reverse Logistics is Mission-critical for OEMs Over the last year, we’ve confronted a new reality in a world that changed rapidly, sometimes daily, for the medtech industry. Supply chain disruption unfolded across the globe early, with widespread ramifications for materials, labor and production. According to recent research by EY, two-thirds of medtech companies…
Confronting the New Post-COVID Complexities of the Orthopedics Industry The orthopedic industry is highly complex and fiercely competitive, which puts significant pressure on OEMs. A rapidly evolving market, complex and highly regulated processes, sourcing and procurement challenges, and difficulty balancing supply and demand can make overall orthopedic complexity more than the sum of its parts.…
The Link Between Quality, Distribution, and Growth for Pharma Devices Poised on the brink of Q2, we’re seeing signs of hope ahead. This is good news, as the last year has been difficult for everyone. Undeniably, it’s been a year of reckoning for the medtech industry. Pharmaceutical device manufacturers (and other medtech OEMs) are still…
How to Shift from Reactive to Proactive Mode in Pharma Device Distribution If you work in pharmaceutical device manufacturing—or in almost any medical manufacturing—you already know how disrupted a time we find ourselves in. We’re in the midst of an unprecedented period of upheaval as OEMs look to build supply chain resilience, address…
Facing the Biggest Risks of the Pharma Device Supply Chain If 2020 was the year of reckoning for medtech supply chains, 2021 will need to be the year of resilience. We recently delved into the vulnerabilities revealed in these supply chains, noting how a perfect storm created unprecedented pressure on firms to address resilience…